Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials-Reference-Cited by-同舟云学术

Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials

Published:2020-12 Issue: Volume:230 Page:71-81
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Shaikh Asim,Ochani Rohan Kumar,Khan Muhammad Shahzeb,Riaz Haris,Khan Safi U.,Sreenivasan Jayakumar,Mookadam Farouk,Doukky Rami,Butler Javed,Michos Erin D.,Kalra Ankur,Krasuski Richard A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Understanding controlled trials. Why are randomised controlled trials important?;Sibbald;BMJ,1998

2. How useful are randomized controlled trials in a rapidly changing world?;Perez-Gomez;Glob Ment Health (Camb),2016

3. Composite end points in clinical research: a time for reappraisal;Armstrong;Circulation,2017

4. Individual and composite study endpoints: separating the wheat from the chaff;Goldberg;Am J Med,2014

5. Composite outcomes in randomized trials: greater precision with greater uncertainty?;Freemantle;JAMA,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-size-fits-all versus risk-category-based screening interval strategies for cardiovascular disease prevention in Chinese adults: a prospective cohort study;The Lancet Regional Health - Western Pacific;2024-08

2. Defining the need for cardiovascular event definitions;European Heart Journal - Quality of Care and Clinical Outcomes;2024-02-01

3. Trials using composite outcomes neglect the presence of competing risks: a methodological survey of cardiovascular studies;Journal of Clinical Epidemiology;2023-08

4. Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus;New England Journal of Medicine;2023-06-08

5. Assessment of Repeat Revascularization in Percutaneous Coronary Intervention Randomized Controlled Trials as a Surrogate for Mortality: A Meta-Regression Analysis;Current Problems in Cardiology;2023-04